A systematic review and critical appraisal of pharmacological treatments for pediatric hidradenitis suppurativa

J Am Acad Dermatol. 2023 Sep;89(3):584-586. doi: 10.1016/j.jaad.2023.04.058. Epub 2023 May 9.

Authors

Ariana Moreno¹, Samuel C Williams¹, Rie Goto², James G Krueger¹, Yael Renert-Yuval³

Affiliations

¹ Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
² Rita and Frits Markus Library, The Rockefeller University, New York, New York.
³ Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York. Electronic address: yrenert@rockefeller.edu.

PMID: 37164242
DOI: 10.1016/j.jaad.2023.04.058

No abstract available

Keywords: antibiotics; biologic treatment; finasteride; hidradenitis suppurativa; metformin; pediatric dermatology; retinoids; spironolactone.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Child
Hidradenitis Suppurativa* / drug therapy
Humans
Immunosuppressive Agents
Metformin*
Systematic Reviews as Topic

Substances

Immunosuppressive Agents
Metformin

Grants and funding

UL1 TR001866/TR/NCATS NIH HHS/United States